Impact Biomedical (IBO) Minority Interest (2022 - 2026)

Impact Biomedical's Minority Interest history runs 5 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• Quarterly Minority Interest rose 9.44% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 9.44% YoY) and the FY2025 annual result came in at $3.2 million, up 8.93% from the prior year.
• Minority Interest was $3.2 million for Q1 2026 at Impact Biomedical, roughly flat from $3.2 million in the prior quarter.
• Across five years, Minority Interest topped out at $3.2 million in Q1 2026 and bottomed at $3.0 million in Q3 2025.
• A 5-year average of $3.1 million and a median of $3.0 million in 2024 frame the typical range for Minority Interest.
• Annual changes were most pronounced in 2024 — Minority Interest fell 2.34% — and 2026, when it grew 9.44%.
• Impact Biomedical's Minority Interest stood at $3.1 million in 2022, then fell by 2.28% to $3.0 million in 2023, then dropped by 2.04% to $3.0 million in 2024, then climbed by 8.93% to $3.2 million in 2025, then advanced by 0.09% to $3.2 million in 2026.
• Business Quant data shows IBO's Minority Interest at $3.2 million in Q1 2026, $3.2 million in Q4 2025, and $3.0 million in Q3 2025.